Şanlı F, Barlak N, Kılınç A, Çapık Özel, Aytatlı A, Karatas OF. The AKT antagonist AZD5363 suppresses features associated with cancer progression in human larynx cancer cells. Eur Res J [Internet]. 2020 Sep. 3 [cited 2026 Apr. 5];6(5):380-7. Available from: https://eurj.org.tr/article/view/448